Development of Immune Cell Targeted TGF-ß Therapies to Restore Tumor Clearance in Cancer Patients

Time: 4:15 pm
day: Day Two


• In cancer patients, TGF-ß mediated immune suppression blocks tumor clearance
• Blockade of TGF-ß signaling in immune cells is necessary and sufficient to rescue tumor clearance
• At Synthis, we are developing first in class therapeutic platform to selectively and safely block TGF-ß mediated immune suppression